Next Article in Journal
Lysozyme Modification Using Proteolytic Enzymes
Next Article in Special Issue
LiOtBu-Promoted Intramolecular 1,3-Dipolar Cycloaddition of the 2′-Alkynyl-biaryl-2-aldehyde N-Tosylhydrazones Approach to 3-Substituted 1H-Dibenzo[e,g]indazoles
Previous Article in Journal
Essential Oil of Bursera morelensis Promotes Cell Migration on Fibroblasts: In Vitro Assays
Previous Article in Special Issue
Friedel–Crafts Reaction of Acylsilanes: Highly Chemoselective Synthesis of 1-Hydroxy-bis(indolyl)methanes and 1-Silyl-bis(indolyl)methanes Derivatives
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Highly Selective Cyclization and Isomerization of Propargylamines to Access Functionalized Quinolines and 1-Azadienes

1
School of Chemistry and Chemical Engineering, Nantong University, Nantong 226019, China
2
Anhui Sholon New Material Technology Co., Ltd., Chuzhou 239500, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2023, 28(17), 6259; https://doi.org/10.3390/molecules28176259
Submission received: 15 July 2023 / Revised: 22 August 2023 / Accepted: 24 August 2023 / Published: 26 August 2023
(This article belongs to the Special Issue Novel Organic Synthetic Route to Heterocyclic Compounds)

Abstract

:
Developing new organic reactions with excellent atom economy and high selectivity is significant and urgent. Herein, by ingeniously regulating the reaction conditions, highly selective transformations of propargylamines have been successfully implemented. The palladium-catalyzed cyclization of propargylamines generates a series of functionalized quinoline heterocycles, while the base-promoted isomerization of propargylamines affords diverse 1-azadienes. Both reactions have good functional group tolerance, mild conditions, excellent atom economy and high yields of up to 93%. More importantly, these quinoline heterocycles and 1-azadienes could be flexibly transformed into valuable compounds, illustrating the validity and practicability of the propargylamine-based highly selective reactions.

Graphical Abstract

1. Introduction

Modern organic reactions utilizing simple precursors that result in the generation of functional and structural diversity are highly attractive for the synthesis of specific molecules, such as natural products, pharmaceuticals and materials. Moreover, the high selectivity of organic reactions is still a subject of heightened concern, especially for multiple possible reactive sites on one substance. Therefore, how to exquisitely control the reaction activity to achieve a highly selective transformation is a significant challenge.
Propargylamines, a versatile class of compounds with unique chemical structures, consist of amine groups and alkyne moieties on the same backbone (Scheme 1) [1]. Compounds with a carbon−carbon triple bond have special reactivity, which can behave both as electrophilic reagents and as a source of electrons in nucleophilic reactions [2]. In addition, the amine moiety of the propargylamine can undergo nucleophilic reactions. This unique characteristic allows propargylamine compounds to act as both electrophilic and nucleophilic substrates in a variety of chemical transformations, such as metal-catalyzed coupling, addition, cycloaddition etc. [3,4,5,6,7,8,9,10,11,12]. It is well known that propargylamines feature wonderful reaction activities and are used as building blocks in manufacturing different organic substrates, natural products and drug candidates, showing broad applications in many fields of chemistry [13,14,15,16,17,18]. Therefore, the development of novel propargylamine-based synthetic methodologies and the construction of functionalized heterocycles or valuable synthetic intermediates are highly desirable, despite significant progress in the functionalization of propargylamines using Au, Ag, Cu, Fe, Hg, microwave, superbase, etc. As shown in Scheme 1 [19,20,21,22,23,24,25,26,27,28,29,30], the development of novel, efficient and practical approaches using mild reaction conditions from easily accessible precursors to enable the highly selective transformation of propargylamines by ingeniously controlling the reaction activity is still a challenging task.
In this study, propargyalmine modules from the Cu-catalyzed A3-coupling of very simple and easily available ingredients, amines, aldehydes and alkynes, are employed for investigating new transformations [31,32,33]. By ingeniously modulating the reaction conditions, the highly selective cyclization and isomerization of propargylamine have been successfully implemented (Scheme 1). Using palladium catalyst, diverse quinolines are obtained, which are widely applicable in drug discovery and material science [34,35,36,37,38,39,40]. Alternatively, in the presence of a base, a series of synthetically valuable 1-azadienes has been smoothly prepared (Scheme 1) [41,42,43,44].

2. Results and Discussion

The Cu(I)-catalyzed A3-coupling of a rich variety of precursors, such as amines, aldehydes and alkynes, was developed by Li and co-workers in 2002 and represents a general and efficient strategy for the synthesis of propargylamines [31]. Herein, to assess the reactivity, propargylamine 1a, which is easily obtained from the A3-coupling of aniline, benzaldehyde and p-tolylacetylene, was selected as a model for selective transformation under different conditions.
At the outset, several commonly used metal catalysts, including palladium, copper, iron and nickel salts, were examined for this reaction, and Pd(OAc)2 exhibited the best reaction activity to solely generate 2a with 65% yield (Table 1, entries 1–9). Subsequently, by screening different solvents (DMSO, NMP, DCE, dioxane, CH3CN and toluene), toluene found to be the most suitable choice, with 80% yield for 2a (Table 1, entries 10–15). Remarkably, the reaction yield of quinoline 2a was greatly reduced by adding TBAI or bases, and a new compound, 1-azadiene 3a, was separated from the reaction system and characterized by NMR and HRMS analyses (Table 1, entries 16–19). The unexpected behavior of the reaction prompted us to deeply investigate the reaction conditions for 1-azadiene formation from propargylamine isomerization. In the presence of Cs2CO3, a series of solvents was evaluated. Notably, CH3CN exhibited a compelling advantage in this isomerization, with a yield of 81% (Table 1, entries 20–24). Further screening of various bases illustrated that Bu4NOAc is the most suitable additive for propargylamine isomerization, with a yield of up to 91% (Table 1, entries 25–29). By systematically modulating the reaction conditions, the rule for the highly selective cyclization and isomerization of propargylamine was successfully mastered. From the palladium-catalyzed cyclization, quinolines were smoothly obtained, whereas in the presence of Bu4NOAc, 1-azadienes could be ingeniously prepared via an isomerization process.
With the optimum reaction conditions established, the generality of the method was investigated in detail. Initially, the scope of the palladium-catalyzed cyclization of propargylamine was explored with respect to the different units of amine, aldehyde and alkyne in the propargylamine structure. As shown in Scheme 2a, a wide range of substituents on the aromatic rings displayed good tolerance under the optimized condition. Propargylamines with either electron-donating (methyl, tert-butyl, methoxyl and phenyl) or electron-withdrawing (fluorine, chlorine and trifluoromethyl) groups can smoothly generate the corresponding quinolines in moderate to good yields. Notably, the aliphatic group (cyclohexyl, 1o) and heteroarene (2-thiophenyl, 1s)-substituted propargylamines are also efficient for this Pd-catalyzed cyclization to afford the expected products in 81% and 72% yields, respectively. More importantly, the gram-scale reaction of propargylamine 1m (4 mmol) efficiently proceeded to afford the quinoline compound 2m in a decent yield of 78% (Scheme 2).
As for Bu4NOAc-promoted isomerization, the scope of substrates was also evaluated using various propargylamines with different substitution patterns and electronic properties. As shown in Scheme 2b, both electron-donating (methyl, tert-butyl, phenyl, naphthyl and methoxyl) and electron-withdrawing (fluorine, chlorine and bromine) groups on the aromatic rings of propargylamines were well tolerated in this isomerization system, affording the corresponding 1-azadienes in excellent yields (81%~93%). It is noteworthy to mention that the halide and methoxyl groups on these products can be further functionalization in preparing other complex and diverse molecules.
To further explore the synthetic utility of this protocol, we employed one of the quinoline 2m as the novel cyclometalated main ligand for constructing the highly efficient red phosphorescent iridium(III) complex Ir-2m, which shows bright red emission with a peak at 605 nm, high photoluminescence quantum yield (PLQY) of 70.12% and a small full width at half maximum (FWHM) value of 46 nm in CH2Cl2, illustrating the potential application in pure red OLED (Figure 1a,b and Figure S1) [45,46]. The application of various isomerization products was also explored. Several functionalized 1-azadienes synthesized in situ from propargylamines have been used to prepare a series of medicinally important dihydropyridin-2(1H)-ones (4a4f) via a [4+2]-formal cycloaddition reaction with homophthalic anhydride under very simple reaction conditions with excellent functional tolerance and good yields (Figure 1c) [47,48].
Based on the above experimental results and previous studies on the functionalization of propargylamines [19,20,21,22,23,24,25,26,27,28,29,30], we also proposed a plausible mechanism for the Pd or base promoting highly selective cyclization and isomerization of propargylamines, as depicted in Scheme 3. Initially, Pd(OAc)2 coordinates with the triple bond (A1) to enhance the electrophilicity of the alkyne part of the propargylamine. The subsequent intramolecular nucleophilic attack by the N-substituted aromatic ring generated intermediate A2. Protonolysis of the resulting intermediate A2 gives dihydroquinoline A3 and releases the palladium catalyst for a new cycle. Then, the generated dihydroquinoline was oxidized by O2 to afford the corresponding quinoline product 2. In the presence of Bu4NOAc, propargylamine 1 first forms allenic intermediate B1, which subsequently undergoes a prototropic isomerization to obtain 1-azadiene 3.

3. Materials and Methods

3.1. General Information

Commercially available reagents were used as received without purification. Raw materials were purchased from Bidepharm and Energy-chemical. Column chromatography was carried out using silica gel (200–300 mesh). Analytical thin–layer chromatography was performed on glass plates of Silica Gel GF–254 using UV detection. 1H, 13C and 19F NMR spectra were recorded on a Bruker AVANCE 400M spectrometer (Bruker, Billerica, MA, USA). The chemical shift references were as follows: 1H NMR (CDCl3) 7.26 ppm; 13C NMR (CDCl3) 77.0 ppm. HRMS spectra were obtained using Micromass GCT (ESI). The photoluminescence spectra were measured using a Hitachi F-4600 photoluminescence spectrophotometer (Hitachi, Kyoto, Japan). The absolute photoluminescence quantum yields (Φ) were measured using a HORIBA FL-3 fluorescence spectrometer (HORIBA, Kyoto, Japan).

3.2. Experimental Section

3.2.1. Synthesis of Propargylamines following Reported Procedures (J. Org. Chem. 2006, 71, 2064–2070; Org. Lett. 2006, 8, 2405–2408; Tetrahedron 2014, 70, 3134–3140)

In a solution of amine (1.0 mmol), aldehyde (1.0 mmo) and alkyne (1.0 mmol) in DCM (10.0 mL), the reaction mixture was stirred at room temperature under nitrogen for 12 h. After removing the solvent using vacuum distillation, the crude mixture was purified via flash column chromatography to obtain the target product propargylamine.

3.2.2. General Procedure for the Preparation of Quinolines through Palladium-Catalyzed Cyclization

In a solution of propargylamine (0.1 mmol) and Pd(OAc)2 (5 mol%) in toluene (2 mL), the reaction mixture was stirred at 80 °C under air for 12 h. After removing the solvent using vacuum distillation, the crude mixture was purified via flash column chromatography to obtain the target product.

3.2.3. General Procedure for the Preparation of 1-Azadienes via Bu4NOAc-Promoted Isomerization

In a solution of propargylamine (0.1 mmol) and Bu4NOAc (0.2 mmol) in CH3CN (2 mL), the reaction mixture was stirred at 80 °C under air for 12 h. After removing the solvent using vacuum distillation, the crude mixture was purified via flash column chromatography to obtain the target product.

3.2.4. General Procedure for the Preparation of Ir-2m

The mixture of 2m (1.0 mmol) and IrCl3 (0.4 mmol) in 2-ethoxyethanol and water (20 mL, 3:1, v/v) was stirred at 130 °C for 24 h under argon. After cooling, the solid precipitate was filtered to obtain a crude cyclometalated Ir(III) chloro-bridged dimer. Then, the slurry of crude chloro-bridged dimer, Na2CO3 (5.0 mmol) and TMHD (5.0 mmol) in 2-ethoxyethanol (30 mL) was reacted at 120 °C for 24 h. The solvent was evaporated at low pressure, and the mixture was poured into water. Next, the mixture was extracted using CH2Cl2 and chromatographed to obtain the complex Ir-2m with a 66% yield.

3.2.5. General Procedure for the Preparation of Dihydropyridin-2(1H)-Ones via Cycloaddition Reaction with 1-Azadienes and Homophthalic Anhydride

In a solution of propargylamine (1.0 mmol) and Bu4NOAc (2.0 mmol) in CH3CN (10 mL), the reaction mixture was stirred at 80 °C under air for 12 h. After cooling to room temperature, homophthalic anhydride (1.0 mmol) was added, and the mixture was stirred at room temperature under air for 12 h. After removing the solvent using vacuum distillation, the crude mixture was purified via flash column chromatography to obtain the target product.

3.3. Characterization of Products

phenyl-4-(p-tolyl)quinoline (2a): White solid, 23.7 mg, 81% yield (Eluent: petroleum ether/ethyl acetate = 50/1). 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 8.4 Hz, 1H), 8.22–8.15 (m, 2H), 7.97–7.84 (m, 1H), 7.81 (s, 1H), 7.73 (ddd, J = 8.4, 6.8, 1.5 Hz, 1H), 7.57–7.39 (m, 6H), 7.36 (d, J = 7.8 Hz, 2H), 2.48 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 156.9, 149.3, 148.8, 139.7, 138.4, 135.5, 130.1, 129.5, 129.5, 129.3, 128.9, 128.2, 127.6, 126.3, 125.9, 125.7, 119.4, 21.3. HRMS (ESI) m/z calcd for C22H17N [M+H]: 296.1439, found: 296.1439.
2,4-diphenylquinoline (2b): Light yellow solid, 19.7 mg, 72% yield (Eluent: petroleum ether/ethyl acetate = 50/1). 1H NMR (400 MHz, CDCl3) δ 8.25 (dd, J = 8.6, 1.3 Hz, 1H), 8.22–8.16 (m, 2H), 7.91 (dd, J = 8.5, 1.4 Hz, 1H), 7.82 (s, 1H), 7.74 (ddd, J = 8.4, 6.8, 1.5 Hz, 1H), 7.61–7.51 (m, 7H), 7.52–7.46 (m, 1H), 7.49–7.42 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 156.9, 149.2, 148.8, 139.7, 138.4, 130.1, 129.6, 129.5, 129.3, 128.8, 128.6, 128.4, 127.6, 126.3, 125.8, 125.6, 123.5, 119.4, 115.9. HRMS (ESI) m/z calcd for C21H15N [M+H]: 282.1283, found: 282.1283.
methyl-2,4-diphenylquinoline (2c): Faint yellow solid, 23.4 mg, 78% yield (Eluent: petroleum ether/ethyl acetate = 50/1). 1H NMR (400 MHz, CDCl3) δ 8.21–8.10 (m, 3H), 7.78 (s, 1H), 7.65 (s, 1H), 7.56 (d, J = 4.4 Hz, 5H), 7.52 (dd, J = 8.2, 6.3 Hz, 3H), 7.49–7.40 (m, 1H), 2.48 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 156.0, 148.5, 147.4, 139.8, 138.6, 136.3, 131.8, 129.8, 129.6, 129.2, 128.8, 128.6, 128.3, 127.5, 125.7, 124.4, 119.4, 21.8. HRMS (ESI) m/z calcd for C22H17N [M+H]: 296.1439, found: 296.1439.
6-(tert-butyl)-2,4-diphenylquinoline (2d): Light yellow solid, 23.6 mg, 70% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 8.23–8.13 (m, 3H), 7.90–7.76 (m, 3H), 7.63–7.39 (m, 8H), 1.35 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 156.3, 149.2, 149.0, 138.6, 129.6, 129.6, 129.2, 128.8, 128.6, 128.4, 128.4, 127.5, 125.3, 120.5, 119.5, 35.1, 31.2. HRMS (ESI) m/z calcd for C25H23N [M+H]: 338.1909, found: 338.1910.
6-methoxy-2,4-diphenylquinoline (2e): Light yellow solid, 24.8 mg, 79% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 8.19–8.11 (m, 3H), 7.77 (s, 1H), 7.58 (s, 1H), 7.59–7.52 (m, 2H), 7.55–7.43 (m, 4H), 7.47–7.33 (m, 2H), 7.19 (d, J = 2.8 Hz, 1H), 3.80 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 157.8, 154.7, 147.8, 144.9, 139.8, 138.7, 131.6, 129.4, 129.0, 128.8, 128.7, 128.4, 127.3, 126.7, 121.8, 119.7, 103.7, 55.5. HRMS (ESI) m/z calcd for C22H17NO [M+H]: 312.1388, found: 312.1388.
6-chloro-2,4-diphenylquinoline (2f): White solid, 22.3 mg, 73% yield (Eluent: petroleum ether/ethyl acetate = 50/1). 1H NMR (400 MHz, CDCl3) δ 8.22–8.14 (m, 3H), 7.89–7.82 (m, 2H), 7.67 (dd, J = 9.0, 2.3 Hz, 1H), 7.62–7.48 (m, 7H), 7.52–7.40 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 157.1, 148.5, 147.2, 139.2, 137.8, 132.2, 131.7, 130.5, 129.6, 129.4, 128.9, 128.8, 128.7, 127.5, 126.5, 124.5, 120.1. HRMS (ESI) m/z calcd for C21H14ClN [M+H]: 316.0893, found: 316.0893.
2,4-diphenylbenzo[g]quinoline (2g): Light yellow solid, 23.2 mg, 71% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 8.27–8.19 (m, 2H), 8.13 (d, J = 9.0 Hz, 1H), 8.00 (d, J = 9.0 Hz, 1H), 7.88 (dd, J = 7.9, 1.5 Hz, 1H), 7.81 (s, 1H), 7.67 (d, J = 8.6 Hz, 1H), 7.60–7.42 (m, 9H), 7.16 (ddd, J = 8.6, 7.0, 1.5 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 155.5, 149.8, 149.2, 143.0, 139.1, 132.9, 131.5, 129.8, 129.3, 129.3, 129.2, 128.9, 128.6, 128.4, 128.1, 128.1, 127.4, 126.5, 125.5, 122.8, 121.8. HRMS (ESI) m/z calcd for C25H17N [M+H]: 332.1439, found: 332.1439.
4-phenyl-2-(p-tolyl)quinoline (2h): Faint yellow solid, 20.9 mg, 73% yield (Eluent: petroleum ether/ethyl acetate = 50/1). 1H NMR (400 MHz, CDCl3) δ 8.23 (dd, J = 8.6, 1.2 Hz, 1H), 8.13–8.06 (m, 2H), 7.89 (dd, J = 8.4, 1.4 Hz, 1H), 7.82–7.68 (m, 2H), 7.60–7.40 (m, 6H), 7.33 (d, J = 8.1 Hz, 2H), 2.43 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 156.9, 149.1, 148.8, 139.5, 138.5, 136.9, 130.1, 129.6, 129.5, 128.6, 128.4, 128.1, 127.5, 126.2, 125.7, 125.6, 119.2, 21.4. HRMS (ESI) m/z calcd for C22H17N [M+H]: 296.1439, found: 296.1438.
2-([1,1′-biphenyl]-4-yl)-4-phenylquinoline (2i): Light yellow solid, 28.7 mg, 81% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 8.32–8.23 (m, 3H), 7.99–7.85 (m, 2H), 7.83–7.65 (m, 5H), 7.58 (s, 2H), 7.57–7.51 (m, 2H), 7.53–7.44 (m, 3H), 7.50–7.31 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 156.5, 149.2, 148.9, 142.1, 140.6, 138.5, 138.4, 130.1, 129.6, 128.8, 128.6, 128.5, 128.0, 127.6, 127.6, 127.2, 126.4, 125.8, 125.7, 119.3. HRMS (ESI) m/z calcd for C27H19N [M+H]: 358.1596, found: 358.1596.
(naphthalen-2-yl)-4-phenylquinoline (2j): Light yellow solid, 23.6 mg, 74% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 8.65 (d, J = 1.7 Hz, 1H), 8.41 (dd, J = 8.6, 1.8 Hz, 1H), 8.30 (dd, J = 8.6, 1.2 Hz, 1H), 8.04–7.84 (m, 5H), 7.76 (ddd, J = 8.4, 6.8, 1.5 Hz, 1H), 7.67–7.45 (m, 8H). 13C NMR (101 MHz, CDCl3) δ 156.7, 149.3, 148.9, 138.5, 136.9, 133.9, 133.5, 130.1, 129.6, 129.5, 128.8, 128.6, 128.6, 128.5, 127.7, 127.2, 126.7, 126.4, 126.3, 125.8, 125.7, 125.1, 124.5, 119.5. HRMS (ESI) m/z calcd for C25H17N [M+H]: 332.1439, found: 332.1439.
(4-fluorophenyl)-4-phenylquinoline (2k): Faint yellow solid, 23.7 mg, 78% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 8.25–8.15 (m, 3H), 7.91 (dd, J = 8.4, 1.4 Hz, 1H), 7.80–7.70 (m, 2H), 7.56 (s, 3H), 7.60–7.50 (m, 2H), 7.48 (ddd, J = 8.3, 6.8, 1.3 Hz, 1H), 7.26–7.16 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 155.8, 149.4, 148.8, 138.3, 135.8, 130.0, 129.7, 129.6, 129.5, 129.4, 128.7, 128.5, 126.4, 125.7, 119.0, 115.9, 115.7. 19F NMR (376 MHz, CDCl3) δ -112.45. HRMS (ESI) m/z calcd for C21H14FN [M+H]: 300.1189, found: 300.1190.
3-phenyl-2-(4-(trifluoromethyl)phenyl)quinoline (2l): Light yellow solid, 24.6 mg, 72% yield (Eluent: petroleum ether/ethyl acetate = 50/1). 1H NMR (400 MHz, CDCl3) δ 8.36–8.30 (m, 2H), 8.27 (d, J = 8.4 Hz, 1H), 7.94 (dd, J = 8.5, 1.4 Hz, 1H), 7.84 (s, 1H), 7.78 (dd, J = 8.5, 6.8 Hz, 3H), 7.60–7.45 (m, 6H). 13C NMR (101 MHz, CDCl3) δ 138.1, 130.2, 129.9, 129.6, 128.7, 128.6, 127.9, 127.0, 126.1, 125.8, 125.8, 119.2, 29.7. 19F NMR (376 MHz, CDCl3) δ -62.56. HRMS (ESI) m/z calcd for C22H14F3N [M+H]: 350.1157, found: 350.1156.
6-(tert-butyl)-4-phenyl-2-(p-tolyl)quinoline (2m): Light yellow solid, 28.3 mg, 82% yield (Eluent: petroleum ether/ethyl acetate = 50/1). 1H NMR (400 MHz, CDCl3) δ 8.16 (d, J = 8.8 Hz, 1H), 8.11–8.04 (m, 2H), 7.88–7.79 (m, 2H), 7.77 (s, 1H), 7.62–7.55 (m, 3H), 7.58–7.46 (m, 2H), 7.32 (d, J = 8.0 Hz, 2H), 2.43 (s, 3H), 1.35 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 156.3, 149.0, 148.8, 147.4, 139.2, 138.7, 137.1, 129.6, 129.6, 128.6, 128.3, 127.4, 125.2, 120.5, 119.3, 35.1, 31.2, 21.4. HRMS (ESI) m/z calcd for C26H25N [M+H]: 352.2065, found: 352.2065.
6-(tert-butyl)-2-(4-fluorophenyl)-4-phenylquinoline (2n): Light yellow solid, 24.9 mg, 71% yield (Eluent: petroleum ether/ethyl acetate = 50/1). 1H NMR (400 MHz, CDCl3) δ 8.21–8.12 (m, 3H), 7.88–7.80 (m, 2H), 7.73 (s, 1H), 7.62–7.52 (m, 4H), 7.52 (ddd, J = 6.6, 5.3, 2.6 Hz, 1H), 7.25–7.14 (m, 2H), 1.35 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 165.0, 162.5, 155.3, 149.3, 149.2, 147.3, 138.6, 136.0, 136.0, 129.5, 129.4, 129.3, 128.6, 128.6, 128.4, 125.2, 120.6, 119.1, 115.9, 115.6, 35.1, 31.2. 19F NMR (376 MHz, CDCl3) δ -112.78. HRMS (ESI) m/z calcd for C25H22FN [M+H]: 356.1815, found: 356.1815.
2-cyclohexyl-4-phenylquinoline (2o): White solid, 20.2 mg, 81% yield (Eluent: petroleum ether/ethyl acetate = 50/1). 1H NMR (400 MHz, CDCl3) δ 8.10–8.01 (m, 1H), 7.79 (dd, J = 8.4, 1.4 Hz, 1H), 7.50–7.38 (m, 6H), 7.19 (d, J = 4.8 Hz, 2H), 2.04–1.95 (m, 3H), 1.85–1.80 (m, 3H), 1.58 (dd, J = 12.4, 3.4 Hz, 2H), 1.42–1.37 (m, 2H), 1.18 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 166.4, 148.7, 148.2, 138.5, 129.6, 129.3, 129.2, 128.5, 128.3, 125.7, 125.6, 125.6, 119.9, 47.7, 32.9, 29.7, 26.6, 26.1. HRMS (ESI) m/z calcd for C21H21N [M+H]: 288.1752, found: 288.1752.
4-(4-methoxyphenyl)-2-phenylquinoline (2p): Light yellow solid, 23.3 mg, 75% yield (Eluent: petroleum ether/ethyl acetate = 50/1). 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 8.5 Hz, 1H), 8.22–8.15 (m, 2H), 7.96 (dd, J = 8.4, 1.4 Hz, 1H), 7.80 (s, 1H), 7.73 (ddd, J = 8.4, 6.8, 1.5 Hz, 1H), 7.58–7.46 (m, 6H), 7.13–7.05 (m, 2H), 3.92 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 159.9, 156.9, 148.9, 139.7, 130.8, 130.7, 130.1, 129.5, 129.3, 128.8, 127.6, 126.2, 126.0, 125.7, 119.3, 114.1, 55.4. HRMS (ESI) m/z calcd for C22H17NO [M+H]: 312.1388, found: 312.1388.
4-(4-fluorophenyl)-2-phenylquinoline (2q): Light yellow solid, 20.9 mg, 71% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 8.26 (dd, J = 8.5, 1.2 Hz, 1H), 8.25–8.15 (m, 2H), 7.88 (dd, J = 8.3, 1.4 Hz, 1H), 7.81 (s, 1H), 7.75 (ddd, J = 8.4, 6.8, 1.4 Hz, 1H), 7.58–7.41 (m, 5H), 7.35 (dt, J = 7.6, 1.3 Hz, 1H), 7.29 (dt, J = 9.4, 2.1 Hz, 1H), 7.26–7.12 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 164.0, 161.6, 156.9, 148.8, 147.8, 147.8, 140.6, 140.5, 139.5, 130.3, 130.2, 129.8, 129.5, 128.9, 127.6, 126.6, 125.4, 125.4, 125.4, 125.3, 119.3, 116.8, 116.6, 115.5, 115.3. 19F NMR (376 MHz, CDCl3) δ -112.48. HRMS (ESI) m/z calcd for C21H14FN [M+H]: 300.1189, found: 300.1189.
4-(4-chlorophenyl)-2-phenylquinoline (2r): Light yellow solid, 22.2 mg, 71% yield (Eluent: petroleum ether/ethyl acetate = 50/1). 1H NMR (400 MHz, CDCl3) δ 8.25 (d, J = 8.4 Hz, 1H), 8.22–8.15 (m, 2H), 7.85 (dd, J = 8.4, 1.4 Hz, 1H), 7.81–7.65 (m, 2H), 7.58–7.43 (m, 8H). 13C NMR (101 MHz, CDCl3) δ 156.9, 148.8, 147.9, 139.5, 136.8, 134.7, 130.9, 130.3, 129.7, 129.5, 128.9, 127.6, 126.6, 125.5, 125.3, 119.3. HRMS (ESI) m/z calcd for C21H14ClN [M+H]: 316.0893, found: 316.0893.
2-phenyl-4-(thiophen-2-yl)quinoline (2s): Light yellow solid, 20.3 mg, 72% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 8.26 (ddd, J = 14.2, 8.5, 1.4 Hz, 2H), 8.21–8.14 (m, 2H), 7.92 (s, 1H), 7.75 (ddd, J = 8.3, 6.8, 1.4 Hz, 1H), 7.59–7.40 (m, 6H), 7.25 (t, J = 4.3 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 156.9, 149.0, 141.5, 139.4, 139.2, 130.2, 129.7, 129.4, 128.9, 128.5, 127.8, 127.6, 127.2, 126.7, 125.4, 125.3, 119.8. HRMS (ESI) m/z calcd for C19H13NS [M+H]: 288.0847, found: 288.0847.
(2E)-N,1-diphenyl-3-(p-tolyl)prop-2-en-1-imine (3a): Light yellow solid, 26.8 mg, 91% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 7.78–7.69 (m, 2H), 7.47 (dd, J = 4.1, 1.8 Hz, 2H), 7.38–7.34 (m, 2H), 7.22–7.08 (m, 6H), 6.93–6.85 (m, 2H), 2.34 (d, J = 11.3 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 167.3 (C=N), 151.0, 141.7, 132.9, 129.8, 129.5, 129.5, 129.4, 128.8, 128.3, 127.5, 127.5, 123.8, 120.8, 21.4. HRMS (ESI) m/z calcd for C22H19N [M+H]: 298.1596, found: 298.1594.
(2E)-N,1,3-triphenylprop-2-en-1-imine(3b): Light yellow solid, 25.3 mg, 88% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 7.75 (t, J = 2.0 Hz, 1H), 7.49 (q, J = 1.4 Hz, 3H), 7.37 (s, 1H), 7.30 (d, J = 9.6 Hz, 7H), 7.13–7.11 (m, 1H), 6.97 (d, J = 1.3 Hz, 1H), 6.92 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 167.2 (C=N), 150.9, 141.7, 139.4, 135.7, 131.6, 129.4, 129.4, 128.9, 128.8, 128.4, 127.5, 124.0, 121.9, 120.8. HRMS (ESI) m/z calcd for C21H17N [M+H]: 284.1439, found: 284.1441.
(2E)-N-(4-(tert-butyl)phenyl)-1,3-diphenylprop-2-en-1-imine (3c): Light yellow solid, 28.3 mg, 85% yield (Eluent: petroleum ether/ethyl acetate = 30/1). 1H NMR (400 MHz, CDCl3) δ 7.74 (t, J = 2.0 Hz, 1H), 7.48 (t, J = 1.7 Hz, 2H), 7.39–7.30 (m, 8H), 6.98–6.92 (m, 3H), 1.36 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 166.9 (C=N), 148.1, 146.9, 141.3, 139.7, 135.9, 132.0, 129.8, 129.4, 128.8, 128.3, 127.5, 125.7, 122.3, 120.8, 34.4, 31.5. HRMS (ESI) m/z calcd for C25H25N [M+H]: 340.2065, found: 340.2063.
(2E)-N-(3-bromophenyl)-1,3-diphenylprop-2-en-1-imine (3d): Light yellow solid, 32.7 mg, 92% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 2.0 Hz, 2H), 7.50 (s, 3H), 7.34–7.29 (m, 2H), 7.14 (t, J = 2.1 Hz, 2H), 6.94 (s, 2H), 6.86 (d, J = 2.6 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 168.0 (C=N), 152.4, 142.7, 138.9, 135.4, 131.1, 130.3, 129.3, 128.9, 128.4, 127.6, 126.8, 124.1, 123.6, 122.7, 121.3, 119.3. HRMS (ESI) m/z calcd for C21H16BrN [M+H]: 362.0544, found: 362.0546.
(2E)-N-(2-bromo-4-fluorophenyl)-1,3-diphenylprop-2-en-1-imine (3e): Light yellow solid, 34.2 mg, 91% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 7.80 (t, J = 1.6 Hz, 2H), 7.50 (d, J = 7.0 Hz, 5H), 7.32 (d, J = 11.7 Hz, 1H), 7.24 (d, J = 11.8 Hz, 2H), 6.95 (s, 1H), 6.87–6.84 (m, 1H), 6.73 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 169.3 (C=N), 157.6, 142.9, 138.5, 135.4, 130.7, 130.2, 129.8, 129.3, 128.9, 128.4, 128.2, 127.7, 121.5, 121.1, 119.9, 115.1, 114.9. 19F NMR (376 MHz, CDCl3) δ -118.89. HRMS (ESI) m/z calcd for C21H15BrFN [M+H]: 380.0450, found: 380.0453.
(2E)-1-([1,1′-biphenyl]-4-yl)-N,3-diphenylprop-2-en-1-imine (3f): Light yellow solid, 32.1mg, 87% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 7.90–7.80 (m, 1H), 7.77–7.57 (m, 4H), 7.59–7.48 (m, 1H), 7.50–7.38 (m, 3H), 7.42–7.32 (m, 3H), 7.35–7.28 (m, 3H), 7.21–7.12 (m, 1H), 7.06–6.88 (m, 3H). 13C NMR (101 MHz, CDCl3) δ 166.8 (C=N), 150.9, 144.8, 142.8, 141.6, 140.5, 139.9, 135.7, 129.9, 129.4, 128.9, 128.8, 128.2, 127.5, 127.2, 127.1, 124.0, 122.0, 120.9. HRMS (ESI) m/z calcd for C27H21N [M+H]: 360.1752, found: 360.1754.
(2E)-1-(naphthalen-2-yl)-N,3-diphenylprop-2-en-1-imine (3g): Light yellow solid, 28.2 mg, 84% yield (Eluent: petroleum ether/ethyl acetate = 30/1). 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 1.7 Hz, 1H), 7.96–7.91 (m, 3H), 7.71–7.68 (m, 1H), 7.40–7.24 (m, 9H), 6.99 (d, J = 7.6 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 167.1 (C=N), 151.0, 144.8, 141.7, 136.8, 135.7, 134.1, 129.4, 128.9, 128.8, 128.8, 127.7, 127.5, 126.4, 124.0, 122.2, 120.8. HRMS (ESI) m/z calcd for C25H19N [M+H]: 334.1596, found: 334.1593.
(2E)-1-(4-fluorophenyl)-N,3-diphenylprop-2-en-1-imine (3h): Light yellow solid,27.4 mg, 93% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 7.76 (d, J = 3.4 Hz, 1H), 7.37–7.24 (m, 6H), 7.16 (d, J = 1.7 Hz, 3H), 6.94 (t, J = 1.1 Hz, 2H), 6.89 (s, 2H). 13C NMR (101 MHz, CDCl3) δ 166.0 (C=N), 150.8, 141.6, 135.5, 131.4, 131.3, 129.5, 128.9, 128.9, 127.5, 124.1, 121.9, 120.8, 115.5, 115.3. 19F NMR (376 MHz, CDCl3) δ -110.92. HRMS (ESI) m/z calcd for C21H16FN [M+H]: 302.1345, found: 302.1347.
(2E)-1-(4-chlorophenyl)-N,3-diphenylprop-2-en-1-imine (3i): Light yellow solid, 28.5 mg, 90% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 7.65–7.59 (m, 2H), 7.46–7.23 (m, 6H), 7.21–7.15 (m, 1H), 7.07 (dt, J = 6.0, 2.6 Hz, 1H), 6.91–6.79 (m, 4H). 13C NMR (101 MHz, CDCl3) δ 165.0 (C=N), 149.6, 140.6, 136.8, 135.0, 134.4, 129.7, 129.4, 128.6, 127.9, 127.8, 127.6, 126.5, 123.1, 119.7. HRMS (ESI) m/z calcd for C21H16ClN [M+H]: 318.1050, found: 318.1046.
(2E)-N,1-bis(4-fluorophenyl)-3-phenylprop-2-en-1-imine (3j): Light yellow solid, 25.5 mg, 81% yield (Eluent: petroleum ether/ethyl acetate = 30/1). 1H NMR (400 MHz, CDCl3) δ 8.11–8.02 (m, 1H), 7.76–7.73 (m, 1H), 7.42 (d, J = 3.0 Hz, 1H), 7.33 (s, 4H), 7.22–7.15 (m, 2H), 7.10–6.99 (m, 2H), 6.90 (t, J = 6.1 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 166.7 (C=N), 146.8, 141.9, 135.4, 134.8, 131.3, 130.7, 129.7, 128.9, 127.5, 122.2, 121.7, 115.8, 115.5, 115.3. 19F NMR (376 MHz, CDCl3) δ -110.63, -119.57. HRMS (ESI) m/z calcd for C21H15F2N [M+H]: 320.1251, found: 320.1253.
(2E)-3-(4-methoxyphenyl)-N,1-diphenylprop-2-en-1-imine (3k): Light yellow solid, 28.3 mg, 92% yield (Eluent: petroleum ether/ethyl acetate = 30/1). 1H NMR (400 MHz, CDCl3) δ 7.74–7.69 (m, 2H), 7.52–7.47 (m, 3H), 7.36 (t, J = 7.8 Hz, 2H), 7.28–7.24 (m, 2H), 7.16–7.11 (m, 2H), 6.87–6.80 (m, 3H), 3.79 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 167.5 (C=N), 160.7, 151.0, 141.5, 139.5, 129.7, 129.4, 129.0, 128.8, 128.6, 128.3, 123.8, 120.8, 119.7, 114.2, 55.3. HRMS (ESI) m/z calcd for C22H19NO [M+H]: 314.1545, found: 313.2672.
(2E)-3-(2-fluorophenyl)-N,1-diphenylprop-2-en-1-imine (3l): Light yellow solid, 27.0 mg, 89% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 7.78–7.70 (m, 1H), 7.54–7.46 (m, 2H), 7.42–7.35 (m, 2H), 7.27 (dq, J = 13.9, 3.2 Hz, 2H), 7.19–7.04 (m, 3H), 6.98 (ddd, J = 16.0, 8.7, 1.2 Hz, 3H), 6.88 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 166.7 (C=N), 150.7, 140.2, 137.9, 133.0, 130.3, 130.3, 129.3, 128.9, 128.4, 124.2, 123.1, 120.7, 116.3, 116.1, 113.9, 113.7. HRMS (ESI) m/z calcd for C21H16FN [M+H]: 302.1345, found: 302.1342.
(2E)-3-(4-fluorophenyl)-N,1-diphenylprop-2-en-1-imine (3m): Light yellow solid, 26.8 mg, 86% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 7.76–7.70 (m, 1H), 7.56–7.44 (m, 2H), 7.41–7.21 (m, 4H), 7.20–7.04 (m, 3H), 7.02–6.86 (m, 4H). 13C NMR (101 MHz, CDCl3) δ 166.7 (C=N), 161.8, 150.7, 140.2, 137.9, 132.9, 130.0, 129.3, 128.9, 128.9, 128.4, 123.1, 120.7, 116.1, 113.7. 19F NMR (376 MHz, CDCl3) δ -112.69. HRMS (ESI) m/z calcd for C21H16FN [M+H]: 302.1345, found: 302.1348.
(2E)-3-(2-chlorophenyl)-N,1-diphenylprop-2-en-1-imine (3n): Light yellow solid, 28.1 mg, 86% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 7.83–7.72 (m, 2H), 7.51–7.49 (m, 2H), 7.38–7.35 (m, 3H), 7.29–7.23 (m, 2H), 7.17–7.12 (m, 2H), 7.00–6.94 (m, 2H), 6.84 (d, J = 16.5 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 166.8 (C=N), 150.9, 139.0, 137.5, 134.3, 134.1, 130.2, 129.9, 129.4, 128.9, 128.6, 128.4, 127.3, 127.0, 124.4, 124.1, 120.7. HRMS (ESI) m/z calcd for C21H16ClN [M+H]: 318.1050, found: 318.1042.
(2E)-N,1-diphenyl-3-(thiophen-2-yl)prop-2-en-1-imine (3o): Light yellow solid, 24.6 mg, 85% yield (Eluent: petroleum ether/ethyl acetate = 40/1). 1H NMR (400 MHz, CDCl3) δ 7.76–7.66 (m, 1H), 7.52–7.43 (m, 2H), 7.41–7.23 (m, 3H), 7.18–6.83 (m, 6H), 6.74–6.62 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 166.8 (C=N), 150.8, 141.0, 139.2, 137.2, 134.4, 132.8, 132.1, 129.3, 128.8, 128.4, 124.0, 121.0, 120.8. HRMS (ESI) m/z calcd for C19H15NS [M+H]: 290.1003, found: 290.1001.
Ir-2m: Red solid, 710.4 mg, 66% yield (Eluent: petroleum ether/dichloromethane = 10/1). 1H NMR (400 MHz, CDCl3) δ 8.19 (d, J = 9.2 Hz, 2H), 7.84 (s, 2H), 7.68–7.59 (m, 4H), 7.58–7.45 (m, 10H), 7.29 (dd, J = 9.2, 2.3 Hz, 2H), 6.68 (d, J = 7.9 Hz, 2H), 6.55 (s, 2H), 4.75 (s, 1H), 1.96 (s, 6H), 1.18 (s, 18H), 0.56 (s, 18H). 13C NMR (101 MHz, CDCl3) δ 192.5, 167.7, 150.9, 148.2, 146.8, 146.8, 143.9, 137.5, 137.0, 136.5, 128.6, 127.6, 127.6, 127.4, 125.9, 123.8, 123.7, 120.7, 119.2, 115.7, 39.5, 33.7, 30.0, 26.8, 20.6. HRMS (ESI) m/z calcd for C63H67IrN2O2 [M+H]: 1077.4910, found: 1077.4910.
4a: Light yellow solid, 358.1 mg, 78% yield (Eluent: dichloromethane/methyl alcohol = 100/1). 1H NMR (400 MHz, DMSO) δ 13.07 (s, 1H), 7.84 (d, J = 7.7 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 7.38 (s, 1H), 7.34–7.16 (m, 10H), 7.15 (d, J = 4.2 Hz, 2H), 7.15–7.07 (m, 1H), 7.06 (d, J = 7.6 Hz, 2H), 5.58 (d, J = 4.3 Hz, 1H), 5.11 (d, J = 8.9 Hz, 1H), 4.35 (dd, J = 8.7, 4.2 Hz, 1H), 2.23 (s, 3H). 13C NMR (101 MHz, DMSO) δ 170.4, 169.3, 141.9, 139.4, 139.3, 136.4, 136.2, 132.0, 131.4, 131.1, 129.5, 128.7, 128.6, 128.5, 128.2, 128.1, 128.0, 127.4, 126.8, 115.2, 44.5, 21.0. HRMS (ESI) m/z calcd for C31H25NO3 [M+H]: 460.1913, found: 460.1914.
4b: Light yellow solid, 364.4 mg, 80% yield (Eluent: dichloromethane/methyl alcohol = 100/1). 1H NMR (400 MHz, DMSO) δ 12.90 (s, 1H), 7.83 (dd, J = 7.7, 1.5 Hz, 1H), 7.42 (d, J = 1.6 Hz, 1H), 7.35–7.27 (m, 5H), 7.30–7.21 (m, 5H), 7.23–7.12 (m, 4H), 7.14–7.07 (m, 2H), 5.61 (d, J = 4.3 Hz, 1H), 5.12 (d, J = 9.1 Hz, 1H), 4.39 (dd, J = 9.2, 4.3 Hz, 1H), 1.19 (s, 9H). 13C NMR (101 MHz, DMSO) δ 170.5, 169.3, 149.0, 142.4, 142.0, 139.4, 136.7, 136.5, 132.0, 131.1, 131.1, 128.9, 128.5, 128.3, 128.2, 128.2, 127.9, 127.4, 127.2, 125.3, 115.1, 45.0, 34.6, 31.5. HRMS (ESI) m/z calcd for C34H31NO3 [M+H]: 502.2382, found: 502.2381.
4c: Light yellow solid, 403.7 mg, 77% yield (Eluent: dichloromethane/methyl alcohol = 100/1). 1H NMR (400 MHz, DMSO) δ 13.05 (s, 1H), 7.84 (dd, J = 8.0, 1.5 Hz, 1H), 7.47–7.36 (m, 3H), 7.34–7.27 (m, 4H), 7.30–7.19 (m, 6H), 7.22–7.11 (m, 4H), 5.63 (d, J = 4.0 Hz, 1H), 5.11 (d, J = 9.7 Hz, 1H), 4.44 (dd, J = 9.7, 4.0 Hz, 1H). 13C NMR (101 MHz, DMSO) δ 170.4, 169.2, 142.4, 141.4, 139.3, 138.8, 136.2, 132.0, 131.6, 131.2, 131.1, 130.9, 128.9, 128.6, 128.4, 128.3, 128.1, 127.4, 127.3, 119.5, 115.6, 45.0. HRMS (ESI) m/z calcd for C30H22BrNO3 [M+H]: 524.0861, found: 524.0860.
4d: White solid, 374.7 mg, 74% yield (Eluent: dichloromethane/methyl alcohol = 100/1). 1H NMR (400 MHz, DMSO) δ 13.10 (s, 1H), 7.84 (d, J = 7.7 Hz, 1H), 7.43–7.33 (m, 3H), 7.28 (dd, J = 14.6, 8.5 Hz, 8H), 7.18 (t, J = 7.1 Hz, 1H), 7.11 (d, J = 8.1 Hz, 2H), 7.02 (t, J = 8.6 Hz, 2H), 5.61 (d, J = 4.2 Hz, 1H), 5.10 (d, J = 9.2 Hz, 1H), 4.45–4.37 (m, 1H), 1.20 (s, 9H). 13C NMR (101 MHz, DMSO) δ 170.3, 169.3, 163.0, 160.6, 149.2, 142.4, 141.0, 139.4, 136.6, 133.0, 132.9, 132.0, 131.2, 131.1, 130.2, 130.1, 128.9, 128.3, 128.2, 127.4, 127.2, 125.4, 115.5, 115.3, 115.1, 45.0, 34.7, 31.5. 19F NMR (376 MHz, DMSO) δ -113.86. HRMS (ESI) m/z calcd for C34H30FNO3 [M+H]: 520.2288, found: 520.2286.
4e: Light yellow solid, 408.1 mg, 79% yield (Eluent: dichloromethane/methyl alcohol = 100/1). 1H NMR (400 MHz, DMSO) δ 13.07 (s, 1H), 7.83 (dd, J = 7.8, 1.4 Hz, 1H), 7.46–7.23 (m, 9H), 7.19 (dd, J = 10.5, 7.6 Hz, 3H), 7.10 (d, J = 8.3 Hz, 2H), 7.00 (d, J = 7.9 Hz, 2H), 5.57 (d, J = 4.4 Hz, 1H), 5.11 (d, J = 8.9 Hz, 1H), 4.35 (dd, J = 9.0, 4.4 Hz, 1H), 2.18 (s, 3H), 1.20 (s, 9H). 13C NMR (101 MHz, DMSO) δ 170.5, 169.3, 149.0, 141.9, 139.4, 137.5, 136.8, 133.6, 132.0, 131.2, 129.1, 128.9, 128.2, 128.1, 127.8, 127.4, 127.2, 125.4, 114.6, 44.9, 34.7, 31.5, 21.1. HRMS (ESI) m/z calcd for C35H33NO3 [M+H]: 516.2539, found: 516.2541.
4f: Light yellow solid, 384.3 mg, 78% yield (Eluent: dichloromethane/methyl alcohol = 100/1). 1H NMR (400 MHz, DMSO) δ 13.12 (s, 1H), 7.95 (s, 1H), 7.84 (dd, J = 12.0, 6.7 Hz, 2H), 7.81–7.75 (m, 1H), 7.68 (d, J = 8.6 Hz, 1H), 7.50–7.15 (m, 15H), 7.04 (t, J = 7.3 Hz, 1H), 5.76 (d, J = 4.2 Hz, 1H), 5.20 (d, J = 9.5 Hz, 1H), 4.49 (dd, J = 9.6, 4.2 Hz, 1H). 13C NMR (101 MHz, DMSO) δ 170.4, 169.3, 142.5, 141.9, 139.4, 139.4, 134.0, 133.0, 132.6, 132.0, 131.2, 131.1, 129.0, 128.8, 128.6, 128.4, 128.3, 127.8, 127.7, 127.4, 127.3, 127.1, 126.9, 126.8, 125.8, 115.7, 45.1. HRMS (ESI) m/z calcd for C34H25NO3 [M+H]: 496.1913, found: 496.1916.

4. Conclusions

In summary, we developed two efficient transformations of versatile propargyalmines by regulating the reaction conditions. Highly selective cyclization catalyzed via Pd(OAc)2 and isomerization promoted by Bu4NOAc from propargylamines was successfully implemented. The strategy characterized by readily available starting materials, operational simplicity, mild conditions, broad functional group tolerance, excellent atom economy and high yields is an important advancement in the development of propargylamine-based synthetic methodology. In addition, we believe that this study reveals a new way to prepare nitrogen-containing heterocycles from simple building blocks of amine, aldehyde and alkyne. Further applications of these diverse quinolines and 1-azadienes are underway in our laboratory.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28176259/s1, Figure S1: The photoluminescence quantum yield (PLQY) of Ir-2m. NMR data and spectra for product 2, 3, 4, and Ir-2m.

Author Contributions

Conceptualization, Z.-G.W., Q.Z. and Y.T.; investigation, H.Z., C.C., C.L., A.J. and J.H.; writing—original draft preparation, Z.-G.W. and Q.Z.; writing—review and editing, Z.-G.W. and Y.T.; supervision, Z.-G.W.; funding acquisition, Z.-G.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China (No. 22005158) and the Program of High Level Talents (No. 03083064, JSSCBS20211122, JB20007).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

NMR and HRMS analyses were carried out using the Large Instruments Open Foundation of Nantong University.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of all compounds are available from the authors.

References

  1. Lauder, K.; Toscani, A.; Scalacci, N.; Castagnolo, D. Synthesis and Reactivity of Propargylamines in Organic Chemistry. Chem. Rev. 2017, 117, 14091–14200. [Google Scholar] [CrossRef] [PubMed]
  2. Trost, B.M.; Li, C.-J. Modern Alkyne Chemistry; Wiley-VCH: Weinheim, Germany, 2014. [Google Scholar]
  3. Trost, B.M.; Lumb, J.-P.; Azzarelli, J.M. An Atom-Economic Synthesis of Nitrogen Heterocycles from Alkynes. J. Am. Chem. Soc. 2011, 133, 740–743. [Google Scholar] [CrossRef] [PubMed]
  4. Zhang, Y.; Liu, X.-K.; Wu, Z.-G.; Wang, Y.; Pan, Y. Solvent controlled radical cyclization of propargylamines for multi-iodinated quinoline formation. Org. Biomol. Chem. 2017, 15, 6901–6904. [Google Scholar] [CrossRef] [PubMed]
  5. Zhu, J.; Sun, S.; Xia, M.; Gu, N.; Cheng, J. Copper-catalyzed radical 1,2-cyclization of indoles with arylsulfonyl hydrazides: Access to 2-thiolated 3H-pyrrolo [1,2-a] indoles. Org. Chem. Front. 2017, 4, 2153–2155. [Google Scholar] [CrossRef]
  6. Sheng, X.; Chen, K.; Shi, C.; Huang, D. Recent Advances in Reactions of Propargylamines. Synthesis 2020, 52, 1–20. [Google Scholar] [CrossRef]
  7. Sadamitsu, Y.; Saito, K.; Yamada, T. Stereoselective amination via vinyl-silver intermediates derived from silver-catalyzed carboxylative cyclization of propargylamine. Chem. Commun. 2020, 56, 9517–9520. [Google Scholar] [CrossRef]
  8. Han, L.; Li, S.-J.; Zhang, X.-T.; Tian, S.-K. Aromatic Aza-Claisen Rearrangement of Arylpropargylammonium Salts Generated in situ from Arynes and Tertiary Propargylamines. Chem. Eur. J. 2021, 27, 3091–3097. [Google Scholar] [CrossRef]
  9. Budi, H.S.; Mustafa, Y.F.; Al-Hamdani, M.M.; Surendar, A.; Ramezani, M. Synthesis of heterocycles from propargylamines. Synth. Commun. 2021, 51, 3694–3716. [Google Scholar] [CrossRef]
  10. Sun, Z.; Chen, L.; Qiu, K.; Liu, B.; Li, H.; Yu, F. Enantioselective Peroxidation of C-alkynyl imines enabled by chiral BINOL calcium phosphate. Chem. Commun. 2022, 58, 3035–3038. [Google Scholar] [CrossRef]
  11. He, X.; Li, R.; Choy, P.Y.; Duan, J.; Yin, Z.; Xu, K.; Tang, Q.; Zhong, R.-L.; Shang, Y.; Kwong, F.Y. An expeditious FeCl3-catalyzed cascade 1,4-conjugate addition/annulation/1,5-H shift sequence for modular access of all-pyrano-moiety-substituted chromenes. Chem. Sci. 2022, 13, 13617–13622. [Google Scholar] [CrossRef]
  12. Chen, Z.; Li, Y.-F.; Tan, S.-Z.; Ouyang, Q.; Chen, Z.-C.; Du, W.; Chen, Y.-C. Formal nucleophilic pyrrolylmethylation via palladium-based auto-tandem catalysis: Switchable regiodivergent synthesis and remote chirality transfer. Chem. Sci. 2022, 13, 12433–12439. [Google Scholar] [CrossRef] [PubMed]
  13. Wu, Z.-G.; Liang, X.; Zhou, J.; Yu, L.; Wang, Y.; Zheng, Y.-X.; Li, Y.-F.; Zuo, J.-L.; Pan, Y. Photocatalyzed cascade oxidative annulation of propargylamines and phosphine oxides. Chem. Commun. 2017, 53, 6637–6640. [Google Scholar] [CrossRef] [PubMed]
  14. Reddy, G.S.; Nallapati, S.B.; Sri Saranya, P.S.V.K.; Sridhar, B.; Giliyaru, V.B.; Hariharapura, R.C.; Shenoy, G.G.; Pal, M. Propargylamine (secondary) as a building block in indole synthesis involving ultrasound assisted Pd/Cu-catalyzed coupling-cyclization method: Unexpected formation of (pyrazole) imine derivatives. Tetrahedron Lett. 2018, 59, 4587–4592. [Google Scholar] [CrossRef]
  15. Shen, J.; Zhao, J.; Hu, B.; Chen, Y.; Wu, L.; You, Q.; Zhao, L. Base-catalysed [3 + 2] cycloaddition of propargylamines and aldehydes to substituted furans. Green Chem. 2018, 20, 600–603. [Google Scholar] [CrossRef]
  16. Lo, V.K.-Y.; Chan, Y.-M.; Zhou, D.; Toy, P.H.; Che, C.-M. Highly Enantioselective Synthesis Using Prolinol as a Chiral Auxiliary: Silver-Mediated Synthesis of Axially Chiral Vinylallenes and Subsequent (Hetero)-Diels–Alder Reactions. Org. Lett. 2019, 21, 7717–7721. [Google Scholar] [CrossRef]
  17. Jiang, X.-L.; Jiao, Y.-E.; Hou, S.-L.; Geng, L.-C.; Wang, H.-Z.; Zhao, B. Green Conversion of CO2 and Propargylamines Triggered by Triply Synergistic Catalytic Effects in Metal–Organic Frameworks. Angew. Chem. Int. Ed. 2021, 60, 20417–20423. [Google Scholar] [CrossRef] [PubMed]
  18. Holsbeeck, K.V.; Elsocht, M.; Ballet, S. Propargylamine Amino Acids as Constrained Nε-Substituted Lysine Mimetics. Org. Lett. 2023, 25, 130–133. [Google Scholar] [CrossRef]
  19. Schmidt, E.Y.; Bidusenko, I.A.; Protsuk, N.I.; Demyanov, Y.V.; Ushakov, I.A.; Vashchenko, A.V.; Trofimov, B.A. Transition-Metal-Free Superbase-Catalyzed C–H Vinylation of Aldimines with Acetylenes to 1-Azadienes. J. Org. Chem. 2020, 85, 3417–3425. [Google Scholar] [CrossRef]
  20. Xiao, F.; Chen, Y.; Liu, Y.; Wang, J. Sequential catalytic process: Synthesis of quinoline derivatives by AuCl3/CuBr-catalyzed three-component reaction of aldehydes, amines, and alkynes. Tetrahedron 2008, 64, 2755–2761. [Google Scholar] [CrossRef]
  21. Zhu, M.; Fu, W.; Xun, C.; Zou, G. An Efficient Synthesis of Substituted Quinolines via Indium (III) Chloride Catalyzed Reaction of Imines with Alkynes. Bull. Korean Chem. Soc. 2012, 33, 43–47. [Google Scholar] [CrossRef]
  22. Cao, K.; Zhang, F.-M.; Tu, Y.-Q.; Zhuo, X.-T.; Fan, C.-A. Iron (III)-Catalyzed and Air-Mediated Tandem Reaction of Aldehydes, Alkynes and Amines: An Efficient Approach to Substituted Quinolines. Chem. Eur. J. 2009, 15, 6332–6334. [Google Scholar] [CrossRef] [PubMed]
  23. Devarajan, N.; Suresh, P. Iron-MOF-Catalyzed Domino Cyclization and Aromatization Strategy for the Synthesis of 2,4-Diarylquinolines. Asian. J. Org. Chem. 2020, 9, 437–444. [Google Scholar] [CrossRef]
  24. Cho, H.; Torok, F.; Torok, B. Energy efficiency of heterogeneous catalytic microwave-assisted organic reactions. Green Chem. 2014, 16, 3623–3634. [Google Scholar] [CrossRef]
  25. Jiang, K.-M.; Kang, J.-A.; Jin, Y.; Lin, J. Synthesis of substituted 4-hydroxyalkyl-quinoline derivatives by a three-component reaction using CuCl/AuCl as sequential catalysts. Org. Chem. Front. 2018, 5, 434–441. [Google Scholar] [CrossRef]
  26. McNulty, J.; Vemula, R.; Bordón, C.; Yolken, R.; Jones-Brando, L. Synthesis and anti-toxoplasmosis activity of 4-arylquinoline-2-carboxylate derivatives. Org. Biomol. Chem. 2014, 12, 255–260. [Google Scholar] [CrossRef]
  27. Zhu, M.; Fu, W.; Zou, G.; Xun, C.; Deng, D.; Ji, B. An efficient synthesis of 2-trifluoromethyl quinolines via gold-catalyzed cyclization of trifluoromethylated propargylamines. J. Fluor. Chem. 2012, 135, 195–199. [Google Scholar] [CrossRef]
  28. Zhang, X.; Yao, T.; Campo, M.A.; Larock, R.C. Synthesis of substituted quinolines by the electrophilic cyclization of n-(2-alkynyl) anilines. Tetrahedron 2010, 66, 1177–1187. [Google Scholar] [CrossRef]
  29. Su, Y.; Lu, M.; Dong, B.; Chen, H.; Shi, X. Silver-Catalyzed Alkyne Activation: The Surprising Ligand Effect. Adv. Synth. Cat. 2014, 356, 692–696. [Google Scholar] [CrossRef]
  30. Kuninobu, Y.; Inoue, Y.; Takai, K. Copper (I)- and Gold (I)-catalyzed Synthesis of 2,4-Disubstituted Quinoline Derivatives from N-Aryl-2-propynylamines. Chem. Lett. 2007, 36, 1422–1423. [Google Scholar] [CrossRef]
  31. Wei, C.; Li, C.-J. Enantioselective Direct-Addition of Terminal Alkynes to Imines Catalyzed by Copper (I) pybox Complex in Water and in Toluene. J. Am. Chem. Soc. 2002, 124, 5638–5639. [Google Scholar] [CrossRef]
  32. Bisai, A.; Singh, V.K. Enantioselective one-pot three-component synthesis of propargylamines. Org. Lett. 2006, 8, 2405–2408. [Google Scholar] [CrossRef]
  33. Ghosh, S.; Biswas, K. Metal-free multicomponent approach for the synthesis of propargylamine: A review. RSC Adv. 2021, 11, 2047–2065. [Google Scholar] [CrossRef] [PubMed]
  34. Park, S.-R.; Seo, J.-S.; Ahn, Y.; Lee, J.-H.; Suh, M.C. Thermally stable benzo [f] quinoline based bipolar host materials for green phosphorescent OLEDs. Org. Electron. 2018, 63, 194–199. [Google Scholar] [CrossRef]
  35. Yu, F.; Liu, Q.; Sheng, Y.; Chen, Y.; Zhang, Y.; Sun, Z.; Zhang, C.; Xia, Q.; Li, H.; Hang, X.-C.; et al. Solution-Processable Csp3-Annulated Hosts for High-Efficiency Deep Red Phosphorescent OLEDs. ACS Appl. Mater. Interfaces 2020, 12, 33960–33967. [Google Scholar] [CrossRef]
  36. Lou, S.-J.; Zhang, L.; Luo, Y.; Nishiura, M.; Luo, G.; Luo, Y.; Hou, Z. Regiodivergent C–H Alkylation of Quinolines with Alkenes by Half-Sandwich Rare-Earth Catalysts. J. Am. Chem. Soc. 2020, 142, 18128–18137. [Google Scholar] [CrossRef] [PubMed]
  37. Matada, B.S.; Pattanashettar, R.; Yernale, N.G. A comprehensive review on the biological interest of quinoline and its derivatives. Bioorg. Med. Chem. 2021, 32, 115973. [Google Scholar] [CrossRef] [PubMed]
  38. Attygalle, A.B.; Hearth, K.B.; Iyengar, V.K.; Morgan, R.C. Biosynthesis of Quinoline by a Stick Insect. J. Nat. Prod. 2021, 84, 527–530. [Google Scholar] [CrossRef] [PubMed]
  39. Xie, R.; Mao, W.; Jia, H.; Sun, J.; Lu, G.; Jiang, H.; Zhang, M. Reductive electrophilic C–H alkylation of quinolines by a reusable iridium nanocatalyst. Chem. Sci. 2021, 12, 13802–13808. [Google Scholar] [CrossRef]
  40. Wang, G.; Jia, J.; Liu, G.; Yu, M.; Chu, X.; Liu, X.; Zhao, X. Copper (i)-catalyzed tandem synthesis of 2-acylquinolines from 2-ethynylanilines and glyoxals. Chem. Commun. 2021, 57, 11811–11814. [Google Scholar] [CrossRef]
  41. Jayakumar, S.; Ishar, M.P.S.; Mahajan, M.P. Recent advances in synthetic applications of azadienes. Tetrahedron 2002, 58, 379–471. [Google Scholar] [CrossRef]
  42. Groenendaal, B.; Ruijtera, E.; Orru, R.V.A. 1-Azadienes in cycloaddition and multicomponent reactions towards N-heterocycles. Chem. Commun. 2008, 43, 5474–5489. [Google Scholar] [CrossRef] [PubMed]
  43. Monbaliu, J.-C.M.; Masscheleina, K.G.R.; Stevens, C.V. Electron-deficient 1- and 2-azabuta-1,3-dienes: A comprehensive survey of their synthesis and reactivity. Chem. Soc. Rev. 2011, 40, 4708–4739. [Google Scholar] [CrossRef] [PubMed]
  44. Yao, P.; Xu, Z.; Yu, S.; Wu, Q.; Zhu, D. Imine Reductase-Catalyzed Enantioselective Reduction of Bulky α,β-Unsaturated Imines en Route to a Pharmaceutically Important Morphinan Skeleton. Adv. Synth. Catal. 2019, 361, 556–561. [Google Scholar] [CrossRef]
  45. Li, T.-Y.; Wu, J.; Wu, Z.-G.; Zheng, Y.-X.; Zuo, J.-L.; Pan, Y. Rational design of phosphorescent iridium (III) complexes for emission color tunability and their applications in OLEDs. Coord. Chem. Rev. 2018, 374, 55–92. [Google Scholar] [CrossRef]
  46. Ou, C.; Qiu, Y.-C.; Cao, C.; Zhang, H.; Qin, J.; Tu, Z.-L.; Shi, J.; Wu, Z.-G. Modulating the peripheral large steric hindrance of iridium complexes for achieving narrowband emission and pure red OLEDs with an EQE up to 32.0%. Inorg. Chem. Front. 2023, 10, 1018–1026. [Google Scholar] [CrossRef]
  47. Nantermet, P.G.; Barrow, J.C.; Selnick, H.G.; Homnick, C.F.; Freidinger, R.M.; Chang, R.S.L.; O’Malley, S.S.; Reiss, D.R.; Broten, T.P.; Ransom, R.W.; et al. Selective α1a Adrenergic Receptor Antagonists Based on 4-Aryl-3,4-dihydropyridine-2-ones. Bioorg. Med. Chem. Lett. 2000, 10, 1625–1628. [Google Scholar] [CrossRef] [PubMed]
  48. Guranova, N.; Golubev, P.; Bakulina, O.; Dar’in, D.; Kantin, G.; Krasavin, M. Unexpected formal [4 + 2]-cycloaddition of chalcone imines and homophthalic anhydrides: Preparation of dihydropyridin-2 (1H)-ones. Org. Biomol. Chem. 2021, 19, 3829–3833. [Google Scholar] [CrossRef]
Scheme 1. Reaction activities of propargylamine and different synthesis strategies for quinolines and 1-azadienes.
Scheme 1. Reaction activities of propargylamine and different synthesis strategies for quinolines and 1-azadienes.
Molecules 28 06259 sch001
Scheme 2. Scope of selective transformations for various propargylamines. (a) All reactions were carried out at the 1 0.1 mmol scale catalyzed by Pd(OAc)2 (5 mol%) in toluene (2.0 mL) at 80 °C for 12 h. (b) All reactions were carried out at the 1 0.1 mmol scale promoted by Bu4NOAc (0.2 mmol) in CH3CN (2.0 mL) at 80 °C for 12 h.
Scheme 2. Scope of selective transformations for various propargylamines. (a) All reactions were carried out at the 1 0.1 mmol scale catalyzed by Pd(OAc)2 (5 mol%) in toluene (2.0 mL) at 80 °C for 12 h. (b) All reactions were carried out at the 1 0.1 mmol scale promoted by Bu4NOAc (0.2 mmol) in CH3CN (2.0 mL) at 80 °C for 12 h.
Molecules 28 06259 sch002
Figure 1. (a) Synthesis of Ir(III) complex from quinoline 2m as the main ligand. (b) The photoluminescence properties of Ir-2m. (c) Application of 1-azadienes for constructing functionalized heterocycles.
Figure 1. (a) Synthesis of Ir(III) complex from quinoline 2m as the main ligand. (b) The photoluminescence properties of Ir-2m. (c) Application of 1-azadienes for constructing functionalized heterocycles.
Molecules 28 06259 g001
Scheme 3. Plausible reaction pathway.
Scheme 3. Plausible reaction pathway.
Molecules 28 06259 sch003
Table 1. Optimization of reaction conditions a.
Table 1. Optimization of reaction conditions a.
Molecules 28 06259 i001
EntryAdditive (Catalyst/Base)SolventYield b
1Pd(dppf)Cl2DMF20%/0
2Pd(PPh3)2Cl2DMF10%/0
3PdCl2DMF31%/0
4Pd(OAc)2DMF65%/0
5Pd(TFA)2DMF45%/0
6CuClDMFtrace/0
7Cu(OAc)2DMF15%/0
8Fe(OTf)3DMFNR/0
9Ni(acac)2DMFtrace/0
10Pd(OAc)2DMSO45%/0
11Pd(OAc)2NMP60%/0
12Pd(OAc)2DCE68%/0
13Pd(OAc)2dioxane25%/0
14Pd(OAc)2CH3CN58%/0
15Pd(OAc)2toluene80%/0
16Pd(OAc)2/TBAItoluene20%/25%
17Pd(OAc)2/KOActoluene41%/trace
18Pd(OAc)2/Na2CO3toluene34%/trace
19Pd(OAc)2/Cs2CO3toluene15%/30%
20Cs2CO3toluene0/31%
21Cs2CO3DCE0/11%
22Cs2CO3dioxane0/35%
23Cs2CO3CH3CN0/81%
24Cs2CO3DMF0/79%
25Na2CO3CH3CN0/21%
26K2CO3CH3CN0/50%
27KOAcCH3CN0/40%
28Bu4NOAcCH3CN0/91%
29DABCOCH3CN0/61%
a Reaction condition: propargylamine 1a (0.1 mmol); catalyst (5 mol%); base (0.2 mmol); solvent (2.0 mL); 80 °C; air; 12 h. b Isolated yield. TBAI = tetrabutylammonium iodide, Bu4NOAc = tetrabutylammonium acetate, and DABCO = 1,4-diazabicyclo [2.2.2]octane.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wu, Z.-G.; Zhang, H.; Cao, C.; Lu, C.; Jiang, A.; He, J.; Zhao, Q.; Tang, Y. Highly Selective Cyclization and Isomerization of Propargylamines to Access Functionalized Quinolines and 1-Azadienes. Molecules 2023, 28, 6259. https://doi.org/10.3390/molecules28176259

AMA Style

Wu Z-G, Zhang H, Cao C, Lu C, Jiang A, He J, Zhao Q, Tang Y. Highly Selective Cyclization and Isomerization of Propargylamines to Access Functionalized Quinolines and 1-Azadienes. Molecules. 2023; 28(17):6259. https://doi.org/10.3390/molecules28176259

Chicago/Turabian Style

Wu, Zheng-Guang, Hui Zhang, Chenhui Cao, Chaowu Lu, Aiwei Jiang, Jie He, Qin Zhao, and Yanfeng Tang. 2023. "Highly Selective Cyclization and Isomerization of Propargylamines to Access Functionalized Quinolines and 1-Azadienes" Molecules 28, no. 17: 6259. https://doi.org/10.3390/molecules28176259

APA Style

Wu, Z. -G., Zhang, H., Cao, C., Lu, C., Jiang, A., He, J., Zhao, Q., & Tang, Y. (2023). Highly Selective Cyclization and Isomerization of Propargylamines to Access Functionalized Quinolines and 1-Azadienes. Molecules, 28(17), 6259. https://doi.org/10.3390/molecules28176259

Article Metrics

Back to TopTop